Arrowhead Pharmaceuticals, Inc.
(NASDAQ : ARWR)

( )
ARWR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.91%69.000.0%$1713.15m
GILDGilead Sciences, Inc. -0.22%73.341.0%$1486.09m
AMGNAmgen, Inc. 0.73%226.431.3%$647.45m
REGNRegeneron Pharmaceuticals, Inc. 1.59%569.912.5%$560.12m
VRTXVertex Pharmaceuticals, Inc. 0.12%284.961.9%$540.88m
NVAXNovavax, Inc. -7.91%46.11102.0%$530.71m
BIIBBiogen, Inc. 0.02%304.531.6%$447.72m
ILMNIllumina, Inc. 1.51%354.703.5%$344.73m
SRNESorrento Therapeutics, Inc. 0.80%5.071.8%$271.93m
SGENSeattle Genetics, Inc. 1.02%155.776.1%$227.64m
ALXNAlexion Pharmaceuticals, Inc. 0.36%101.502.0%$215.96m
CODXCo-Diagnostics, Inc. 2.94%18.550.0%$192.06m
AAgilent Technologies, Inc. 5.24%84.981.6%$187.17m
IMMUImmunomedics, Inc. -0.69%34.4711.0%$184.11m
MGNXMacroGenics, Inc. 0.84%25.376.2%$182.51m

Company Profile

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.